Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients

被引：7
|
作者：
Fisher, RA
Pan, SH
Rossi, SJ
Schroeder, TJ
Irish, WD
Canafax, DM
Lopez, RR
机构：
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Surg, Richmond, VA 23298 USA
[2] St Vincent Med Ctr, Comprehens Liver Dis Ctr, Los Angeles, CA USA
[3] SangStat Med Corp, Menlo Park, CA USA
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(98)01676-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：394 / 395
页数：2
相关论文
共 25 条
  • [1] Comparison of two cyclosporine formulations in healthy volunteers: Bioequivalence of the new Sang-35 formulation and neoral
    Schroeder, TJ
    Cho, MJ
    Pollack, GM
    Floc'h, R
    Moran, HB
    Levy, R
    Moore, LW
    Pouletty, P
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (09): : 807 - 814
  • [2] Bioequivalence comparison of Sandimmune(R) and Neoral(R) versus Sang-35 cyclosporine in kidney transplant recipients.
    Alloway, R
    Schroeder, T
    Russell, W
    Moore, L
    Burton, M
    Shah, M
    Gaber, AO
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3134 - A3134
  • [3] Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
    First, MR
    Weiskittel, P
    Shah, M
    Peddi, VR
    Canafax, D
    Schroeder, TJ
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 3955 - 3957
  • [4] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [5] Conversion from cyclosporine to neoral in stable liver transplant recipients
    Jain, A
    Gadomski, M
    Fung, J
    [J]. HEPATOLOGY, 1996, 24 (04) : 191 - 191
  • [6] Pharmacokinetic and clinical evaluation of SangCya and Neoral in stable, adult renal transplant patients: Preliminary results
    Gaston, RS
    Said, M
    Ward, M
    Jones, P
    [J]. TRANSPLANTATION, 1999, 67 (07) : S161 - S161
  • [7] A pharmacokinetic conversion study of Abbott cyclosporine and Neoral® in stable renal transplant recipients
    Tomlanovich, S
    Pollak, R
    Roza, A
    Merion, R
    Scandling, J
    Greco, R
    Dubé, L
    Awni, W
    Nabulsi, A
    [J]. TRANSPLANTATION, 1999, 67 (07) : S163 - S163
  • [8] Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method
    First, MR
    Weiskittel, P
    Burton, M
    Shah, M
    Dreyer, D
    Fleck, P
    Bey, C
    Peddi, R
    Canafax, D
    Schroeder, TJ
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1701 - 1705
  • [9] Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients
    van Mourik, IDM
    Thomson, M
    Kelly, DA
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (02): : 107 - 111
  • [10] A Bioavailability Study of Cyclosporine: Comparison of Neoral Versus Cysporin in Stable Heart Transplant Recipients
    Leet, Angeline
    Richardson, Meroula
    Senior, Jodie-Anne
    Funston, Robyn
    Skiba, Marina
    Bailey, Michael
    Krum, Henry
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (09): : 894 - 898
123